Follow the people · Insider
Lantheus Holdings, Inc.
Lantheus Holdings, Inc. files insider transactions with the SEC as a 10% owner of Perspective Therapeutics (CATX). We hold 2 disclosed purchases and sales filed since 2 September 2026, 2 of them in the last 90 days.
- Files forCATX
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure3 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 31 August 2026 — 1 September 202610% owner · Perspective Therapeutics (CATX)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
2 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 35,769 shares of Perspective TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- ▼ sold on the open market 78,145 shares of Perspective TherapeuticsSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.